Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-13

Clinical Trial Update: Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating fluorescence imaging to locate renal cell carcinoma tumors in patients with kidney cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer | Phase 1 | Status: COMPLETED